Claims-based reconstruction of the pancreatic cancer care pathway links centralization of care to survival
Laubr, D.; Tichopad, A.; Rybar, M.; Bielcikova, Z.; Lovecek, M.; Rozanek, M.; Donin, G.
Show abstract
Background: The organization of pancreatic cancer care may be associated with survival. Using health administrative claims data, we reconstructed the pathway from diagnosis to first-line therapy and examined associations of multidisciplinary team review and treatment at specialized centers with overall survival. Methods: Longitudinal historical cohort study using anonymized health administrative claims data from six Czech health insurance funds, covering approximately 17% of patients diagnosed with pancreatic cancer nationally between 2018 and 2020. Adults with an incident ICD-10 C25 record confirmed by imaging and histopathology were followed from the index date (the date of the first qualifying imaging or histopathological examination) until death, censoring, or 31 December 2021. Overall survival was analyzed using Kaplan-Meier methods and Cox regression adjusted for age and first-line therapy type. Results: Of 1,255 patients, 920 (73.3%) received first-line therapy and 266 (21.2%) died untreated. Among treated patients, 436 (47.4%) underwent multidisciplinary team review, 335 (36.4%) underwent surgery, and 667 (72.5%) were treated at a complex oncological center. Surgery was associated with longer overall survival than chemotherapy (age-adjusted hazard ratio [HR] 0.32, P < 0.001). Treatment at a complex oncological center was associated with longer overall survival (adjusted HR 0.77, 95% confidence interval [CI] 0.64-0.92, P = 0.004; crude median 532 versus 394 days). Multidisciplinary team review was not significantly associated with overall survival (adjusted HR 0.86, 95% CI 0.73-1.01, P = 0.073). Conclusions: Treatment at a complex oncological center was associated with longer survival, while fewer than half of patients had a recorded multidisciplinary team review. How care is organized, not only which therapy is delivered, is associated with outcome. The observational design and absence of key clinical covariates limit causal interpretation.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer 91%
- Multi-centre derivation and validation of a colitis-associated colorectal cancer risk prediction web-tool 90%
- GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma 90%
Similar papers in this journal
- The systemic activin response to pancreatic cancer: Implications for effective cancer cachexia therapy 90%
- From Symptom to Outcome: Defining Clinically Meaningful Patient-Reported Appetite Loss in Non-Small-Cell Lung Cancer 89%
- Macrophages protect against loss of adipose tissue during cancer cachexia 86%
Similar papers in this journal
- KRAS inhibition in pancreatic cancer: pooled efficacy and safety signals from early-phase studies 91%
- Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers 91%
- Identification of patients at risk for pancreatic cancer in a 3-year timeframe based on machine learning algorithms 91%
Similar papers in this journal
- Cancer and the risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort study including 4,618,377 adults in Catalonia, Spain 91%
- Age-related differences in cancer relative survival in the US: a SEER-18 analysis 90%
- Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy 90%
Similar papers in this journal
- Dragon III- Phase II Randomized Controlled Trial: Neoadjuvant FLOT versus SOX for Patients with Locally Advanced Gastric Cancer 90%
- Deciphering the Role of Complement System Genes in Pancreatic Cancer Susceptibility and Prognosis 90%
- Genome-wide association meta-analysis identifies novel GP2 gene risk variants for pancreatic cancer in the Japanese population 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.